Evidence map›Paper›PMID 27716783›Full record

ArticlePloS one2016

Functional Properties of Mouse Chitotriosidase Expressed in the Periplasmic Space of Escherichia coli.

Masahiro Kimura, Satoshi Wakita, Kotarou Ishikawa, Kazutaka Sekine, Satoshi Yoshikawa, Akira Sato, Kazuaki Okawa, Akinori Kashimura, Masayoshi Sakaguchi, Yasusato Sugahara and 4 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.0field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Chitins and chitinase activity in airway diseases.The Journal of allergy and clinical immunology · 2018
    Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 2 countries.

Masahiro KimuraDepartment of Chemistry and Life Science, Kogakuin University, Hachioji, Tokyo, 192-0015, Japan.
Satoshi WakitaDepartment of Chemistry and Life Science, Kogakuin University, Hachioji, Tokyo, 192-0015, Japan.
Kotarou IshikawaDepartment of Chemistry and Life Science, Kogakuin University, Hachioji, Tokyo, 192-0015, Japan.
Kazutaka SekineDepartment of Chemistry and Life Science, Kogakuin University, Hachioji, Tokyo, 192-0015, Japan.
Satoshi YoshikawaDepartment of Chemistry and Life Science, Kogakuin University, Hachioji, Tokyo, 192-0015, Japan.
Akira SatoDepartment of Chemistry and Life Science, Kogakuin University, Hachioji, Tokyo, 192-0015, Japan.
Kazuaki OkawaDepartment of Chemistry and Life Science, Kogakuin University, Hachioji, Tokyo, 192-0015, Japan.
Akinori KashimuraDepartment of Chemistry and Life Science, Kogakuin University, Hachioji, Tokyo, 192-0015, Japan.
Masayoshi SakaguchiDepartment of Chemistry and Life Science, Kogakuin University, Hachioji, Tokyo, 192-0015, Japan.
Yasusato SugaharaDepartment of Chemistry and Life Science, Kogakuin University, Hachioji, Tokyo, 192-0015, Japan.
Daisuke YamanakaLaboratory for Immunopharmacology of Microbial Products, Tokyo University of Pharmacy and Life Sciences, Hachioji, Tokyo, 192-0392, Japan.
Naohito OhnoLaboratory for Immunopharmacology of Microbial Products, Tokyo University of Pharmacy and Life Sciences, Hachioji, Tokyo, 192-0392, Japan.
Peter O BauerDepartment of Neuroscience, Mayo Clinic, Jacksonville, FL, 32224, United States of America.
Fumitaka OyamaDepartment of Chemistry and Life Science, Kogakuin University, Hachioji, Tokyo, 192-0015, Japan.ORCID http://orcid.org/0000-0002-1095-8306
Kogakuin University · JPTokyo University of Pharmacy and Life Sciences · JPMayo Clinic in Florida · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chitotriosidase (Chit1) is an enzyme associated with various diseases, including Gaucher disease, chronic obstructive pulmonary disease, Alzheimer disease and cystic fibrosis. In this study, we first expressed mouse mature Chit1 fused with V5 and (His)6 tags at the C-terminus (Chit1-V5-His) in the cytoplasm of Escherichia coli and found that most of the expressed protein was insoluble. In contrast, Chit1 tagged with Protein A at the N-terminus and V5-His at the C-terminus, was expressed in the periplasmic space of E. coli as a soluble protein and successfully purified. We evaluated the chitinolytic properties of the recombinant enzyme using 4-nitrophenyl N,N'-diacetyl-β-D-chitobioside [4NP-chitobioside, 4NP-(GlcNAc)2] and found that its activity was comparable to CHO cells-expressed Chit1-V5-His. Optimal conditions for the E. coli-produced Chit1 were pH ~5.0 at 50°C. Chit1 was stable after 1 h incubation at pH 5.0~11.0 on ice and its chitinolytic activity was lost at pH 2.0, although the affinity to chitin remained unchanged. Chit1 efficiently cleaved crystalline and colloidal chitin substrates as well as oligomers of N-acetyl-D-glucosamine (GlcNAc) releasing primarily (GlcNAc)2 fragments at pH 5.0. On the other hand, (GlcNAc)3 was relatively resistant to digestion by Chit1. The degradation of 4NP-(GlcNAc)2 and (GlcNAc)3 was less evident at pH 7.0~8.0, while (GlcNAc)2 production from colloidal chitin and (GlcNAc)6 at these pH conditions remained strong at the neutral conditions. Our results indicate that Chit1 degrades chitin substrates under physiological conditions and suggest its important pathophysiological roles in vivo.

Indexed as

Amino Acid SequenceAnimalsCell LineChitinCHO CellsCricetulusEscherichia coliHexosaminidasesHydrogen-Ion ConcentrationMicePeriplasmStaphylococcal Protein AChitinchitotriosidaseHexosaminidasesStaphylococcal Protein A

Identifiers

PMID27716783
PMCPMC5055312
OpenAlexW2529525510

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.